Status:
COMPLETED
Study of a Dialysate Without Acetate on Protein Energy Wasting Syndrome in Chronic Hemodialysis Patient (EASY)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
INRAE
Conditions:
End Stage Renal Disease
Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This work aims to study the effect of an acetate-free dialysate on protein-energy wasting syndrome in patients with chronic hemodialysis renal failure, in comparison to a conventional dialysate with a...
Detailed Description
The dialysate usually used at the Clermont Ferrand CHU dialysis center is a dialysate containing acetate After inclusion, patients will be randomly divided into two groups. Patients in group 1 will fi...
Eligibility Criteria
Inclusion
- Major patient;
- Man or woman ;
- Treated with intermittent hemodialysis for chronic renal failure;
- Affiliated with a social security scheme;
- Having given a signed agreement after detailed explanation of the protocol on the basis of the information sheet and likely to comply with it
Exclusion
- Patient with lower limb amputation more proximal than a transmetatarsal amputation (invalidity of the model for estimating body composition by BCM in this situation)
- Acute event in the 3 months preceding inclusion (infection, surgery).
- Having a neuromuscular pathology responsible for a motor deficit.
- Whose life expectancy does not exceed 6 months
- With a psychiatric pathology or cognitive impairment rendering him unable to give informed consent
- Pregnant women
- Patient under guardianship, curatorship or legal protection
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04824885
Start Date
February 15 2022
End Date
March 6 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000